title: Bosentan.
authors: All Children’s Hospital/Jonhs Hopkins Medicine, St. Petersburg, Florida, USA. sbell42104@aol.com
authors: Susan Givens
authors: SG
authors: Bell
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077300:Bosentan; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy / Q000451:nursing / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D016232:Endothelins / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000188:drug therapy / Q000451:nursing / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000451:nursing* / Q000503:physiopathology; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000451:nursing* / Q000503:physiopathology; D008297:Male; D010100:Oxygen / Q000097:blood; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D016232:Endothelins; D013449:Sulfonamides; D000077300:Bosentan; D010100:Oxygen